Scaling down imaging: Molecular mapping of cancer in mice

Nature Reviews Cancer

Volumn 2, Issue 1, 2002, Pages 11-18

  Weissleder, Ralph ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBON 11; DYSPROSIUM; FLUORESCENT DYE; FLUORINE 18; GADOLINIUM; INDIUM 111; IODINE; IRON OXIDE; LUCIFERIN; OXYGEN 15; TECHNETIUM 99M; TUMOR PROTEIN;

CANCER; CANCER LOCALIZATION; CARCINOGENESIS; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; HUMAN; IMAGE ANALYSIS; IMAGING SYSTEM; KNOCKOUT MOUSE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TRANSGENIC MOUSE; ANIMAL; CHEMISTRY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONFOCAL MICROSCOPY; DIAGNOSTIC IMAGING; ELECTRONICS; EXPERIMENTAL NEOPLASM; FLUOROMETRY; HISTOLOGY; IMAGE PROCESSING; INSTRUMENTATION; LUMINESCENCE; METABOLISM; METHODOLOGY; MOUSE MUTANT; NANOTECHNOLOGY; PATHOLOGY; RADIOGRAPHY;

ANIMALS; DIAGNOSTIC IMAGING; FLUOROMETRY; IMAGE PROCESSING, COMPUTER-ASSISTED; LUMINESCENT MEASUREMENTS; MAGNETIC RESONANCE IMAGING; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; MINIATURIZATION; NANOTECHNOLOGY; NEOPLASM PROTEINS; NEOPLASMS, EXPERIMENTAL; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 0036359767     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrc701     Document Type: Review

References (69)

1. DePinho, R. A. The age of cancer Nature 408, 248-254 (2000).
2. Attardi, L. D. & Jacks, T. The role of p53 in tumour suppression: lessons from mouse models. Cell. Mol. Life Sci. 55, 48-63 (1999).
3. Artandi, S. et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406, 641-645 (2000).
4. Gillies, R. et al. Applications of magnetic resonance in model systems: tumor biology and physiology. Neoplasia 2, 139-151 (2000).
5. Lewin, M. et al. In vivo assessment of vascular endothelial growth factor-induced angiogenesis. Int. J. Cancer 83, 798-802 (1999).
6. Taylor, J. S. et al. MR imaging of tumor microcirculation: promise for the new millennium. J. Magn. Reson. Imaging 10, 903-907 (1999).
7. Weissleder, R., Cheng, H., Marecos, E., Kwong, K. & Bogdanov, A. Mapping of tumor vascular and interstitial volume fractions non-invasively in vivo. Eur. J. Cancer 34, 1448-1454 (1998).
8. Mandeville, J. B. et al. Dynamic functional imaging of relative cerebral blood volume during rat forepaw stimulation. Magn. Reson. Med. 39, 615-624 (1998).
9. Neeman, M., Dafni, H., Bukhan, O., Braun, R. D. & Dewhirst, M. W. In vivo BOLD contrast MRI mapping of subcutaneous vascular function and maturation: validation by intravital microscopy. Magn. Reson. Med. 45, 887-898 (2001).
10. Brasch, R. et al. Assessing tumor angiogenesis using macromolecular MR imaging contrast media. J. Magn. Reson. Imaging 7, 68-74 (1997).
11. Dennie, J. et al. NMR imaging of changes in vascular morphology due to tumor angiogenesis Magn. Reson. Med. 40, 793-799 (1998).
12. Koutcher, J. A., Zakian, K. & Hricak, H. Magnetic resonance spectroscopic studies of the prostate. Mol. Urol. 4, 143-152; discussion 153 (2000).
13. Sipkins, D. A. et al. Detection of tumor angiogenesis in vivo by αVβ3-targeted magnetic resonance imaging, Nature Med. 4, 623-626 (1998).
14. Bogdanov, A., Matuszewski, L., Bremer, C., Petrovsky, A. & Weissleder, R, Oligomerization of paramagnetic substrates result in signal amplification and can be used for MR imaging of molecular targets. Mol. Imaging 1, 1-9 (2001).
15. Weissleder, R. et al. In vivo magnetic resonance imaging of transgene expression. Nature Med. 6, 351-355 (2000).
16. Josephson, L., Perez, M. & Weissleder, R. Magnetic nanosensors for the detection of oligonucleotide sequences. Angew. Chem. (Int Ed. Engl.) 40, 3204-3206 (2001). Describes the use of magnetic nanoparticles as sensors to read out DNA hybridization and, potentially, interactions between large and small molecules. Similar nanoparticles are also used for imaging of other molecular targets by high-resolution MRI.
17. Lewin, M. et al. Tat peptide-derevatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nature Biotechnol. 18, 410-414 (2000). Describes a versatile magnetic label that can be used to image a variety of cell types in vivo. Labelled cells were isolated after intravenous injection using a magnetic separation column.
18. Kennel, S. J. et al. High resolution computed tomography and MRI for monitoring lung tumor growth in mice undergoing radioimmunotherapy: correlation with histology. Med. Phys. 27, 1101-1107 (2000).
19. Borah, B. et al. Three-dimensional microimaging (MRmicrol and microCT), finite element modeling, and rapid prototyping provide unique insights into bone architecture in osteoporosis. Anat. Rec. 265, 101-101 (2001).
20. Paulus, M. J., Gleason, S. S., Kennel, S. J., Hunsicker, P. R. & Johnson, D. K. High resolution X-ray computed tomography: an emerging tool for small animal cancer research. Neoplasia 2, 62-70 (2000).
21. Paulus, M. J., Gleason, S. S., Easterly, M. E. & Foltz, C. J. A review of high-resolution X-ray computed tomography and other imaging modalities for small animal research. Lab. Anim. (NY) 30, 36-45 (2001).
22. Turnbull, D. et al. Ultrasound backscatter microscope analysis of mouse melanoma progression. Ultrasound Med. Biol. 22, 845-853 (1996).
23. Rooks, V., Beecken, W., Iordanescu, I. & Taylor, J. A. Sonographic evaluation of orthopic bladder tumors in mice treated with, TNP-470, an angiogenesis inhibitor. Acad. Radiol. 8, 121-127 (2001).
24. Drevs, J. et al. Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model. Cancer Res. 60, 4819-4824 (2000).
25. Zagar, B., Fornaris, R. & Ferrara, K. Ultrasonic mapping of the microvasculature: signal alignment. Ultrasound Med. Biol. 24, 809-824 (1998).
26. Ferrara, K. W. et al. Evaluation of tumor angiogenesis with US: imaging, Doppler, and contrast agents. Acad. Radiol. 7, 824-839 (2000).
27. Turnbull, D. H., Bloomfield, T. S., Baldwin, H. S., Foster, F. S & Joyner, A. L. Ultrasound backscatter microscope analysis of early mouse embryonic brain development. Proc. Natl Acad. Sci. USA 92, 2239-2243 (1995).
28. Liu, A., Joyner, A. L. & Turnbull, D. H. Alteration of limb and brain patterning in early mouse embryos by ultrasound-guided injection of Shh-expressing cells. Mech. Dev. 75, 107-115 (1998).
29. Haubner, R. et al. Noninvasive imaging of α(v)β3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography. Cancer Res. 61, 1781-1785 (2001).
30. 8F]FLT and positron emission tomography. Nature Med. 4, 1334-1336 (1998).
31. Price, R. Positron emission tomography (PET) in diagnostic oncology: is it a necessary tool today ? Eur. J. Cancer 36, 691-693 (2000).
32. MacLaren, D. C. et al. Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals. Gene Ther. 6, 785-791 (1999).
33. Yarg, D. et al. Imaging, biodistribution and therapeutic potential of halogenated tamoxifen analogues. Life Sci. 55, 53-67 (1994).
34. Tjuvajev, J. G. et al. Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: a pothential method for monitoring clinical gene therapy. Cancer Res. 56, 4087-4095 (1996).
35. Gambhir, S. S. et al. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc. Natl Acad. Sci. USA 96, 2333-2338 (1999).
36. Luker, G. & Piwnica-Worms, D. Beyond the genome: molecular imaging in vivo with PET and SPECT. Acad. Radiol. 8, 4-14 (2001).
37. Gambhir, S. et al. imaging transgene expression with radionuclide imaging technologies. Neoplasia 2, 118-138 (2000).
38. Gambhir, S., Bardo, J., Herschman, H. & Phelps, M. Assays for non-invasive imaging of reporter gene expression. Nucl Med. Biol. 26, 481-490 (1999).
39. Tjuvajev, J. G. et al. Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo. Cancer Res. 59, 5186-5193 (1999).
40. Doubrovin, M. et al. Imaging transcriptional regulation of p53-dependent genes with positron emission tomography in vivo. Proc. Natl Acad. Sci. USA 98, 9300-9305 (2001).
41. Boland, A. et al. Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy, Cancer Res. 60, 3484-3492 (2000).
42. Groch, M. W. & Erwin W. D. Single-photon emission computed tomography in the year 2001: instrumentation and quality control. J. Nucl. Med. Technol. 29, 12-18 (2001).
43. Blankenberg, F. G. et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc. Natl Acad. Sci. USA 95, 6349-6354 (1998).
44. Rogers, B. et al. Localization of iodine-125-mIP-Des-Met14-bombesin (7-13)NH2 in ovarian carcinoma induced to express the gastrin releasing peptide receptor by adenoviral vector-mediated gene transfer J. Nucl. Med. 38, 1221-1229 (1997).
45. Bogdanov, A., Tung, C., Kayne, L., Hnatowich, D. J. & Weissleder, R. in NASA-NCI Workshop on Sensors for Bio-Molecular Signatures 170 (Pasadena, 1999).
46. Hnatowich, D. J, et al. Technetium-99m labeling of DNA oligonucleotides. J. Nucl. Med. 36, 2306-2314 (1995).
47. Zalutsky, M. R. et al. Radioiodinated antibody targeting of the HER-2/ neu oncoprotein: effects of labeling method on cellular processing and tissue distribution. Nucl. Med. Biol. 26, 781-790 (1999).
48. Zinn, K. R., Chaudhudri, T. R., Buchsbaum, D. J., Mountz, J. M. & Rogers, B. E. Simultaneous evaluation of dual gene transfer to adherent cells by gamma-ray imaging. Nucl. Med. Biol. 28, 135-144 (2001).
49. Katzenellenbogen, J. A. et al. Tumor receptor imaging: proceedings of the National Cancer Institute workshop, review of current work, and prospective for further investigations. Clin. Cancer Res. 1, 921-932 (1995).
50. Hom, R. K. & Katzenellenbogen, J. A. Technetium-99m-labeled receptor-specific small-molecule radiopharmaceuticals: recent developments and encouraging results. Nucl. Med. Biol. 24, 485-498 (1997).
51. Melder, R. et al. Systemic distribution and tumor localization of adoptively transferred lymphocytes in mice: comparison with physiologically based pharmacokinetic model Neoplasia (in the press).
52. Schellingerhout, D., Rainov, N.,Breakefield, X. & Weissleder, R. Quantitation of HSV mass distribution in a rodent brain tumor model. Gene Ther. 7,1648-1655 (2000).
53. Mahmood, U., Tung, C. H., Bogdanov, A., Jr & Weissleder, R. Near-infrared optical imaging of protease activity for tumor detection. Radiology 213, 866-870 (1999).
54. Kaneko, K. et al. Detection of peritoneal micrometastases of gastric carcinoma with green fluorescent protein and carcinoembryonic antigen promoter. Cancer Res. 61, 5570-5574 (2001).
55. Becker, A. et al. Receptor targeted optical imaging of tumors with near infrared flurorescent ligands. Nature Biotechnol. 19, 327-331 (2001).
56. Folli, S. et al. Antibody-indocyanin conjugates for immunophotodetection of human squamous cell carcinoma in nude mice. Cancer Res. 54, 2643-2649 (1994).
57. Weissleder, R., Tung, C. H. Mahmood, U. & Bogdanov, A. Jr. in vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nature Biotechnol. 17, 375-378 (1999).
58. Bremer, C., Tung, C. H. & Weissleder, R. In vivo molecular target assessment of matrix metalloproteinase inhibition. Nature Med. 7, 743-748 (2001). Describes novel fluorescent sensors that are specific for proteinases, and explains how they can be used to image therapeutic proteanase inhibition in vivo.
59. Tung, C. H., Mahmood, U., Bredow, S. & Weissleder, R. In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res. 60, 4953-4958 (2000).
60. Shalinsky, D. R. et al. Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials. Ann. NY Acad. Sci. 878, 236-270 (1999).
61. Marten, K. et al. Detection of dysplastic intestinal adenomas using enzyme sensing molecular beacons. Gastroenterology (in the press).
62. Ntziachristos, V. & Weissleder, R. Experimental three-dimensional fluorescence reconstruction of diffuse media by use of a normalized Born approximation. Optics Lett. 26, 893-895 (2001).
63. Ntziachristos, V., Ripoll, J. & Weissleder, R. Can near-infrared fluorescence propagate through human organs for non-invasive clinical examinations? Optics Lett. (in the press).
64. Ntziachristos, V., Yodh, A. G. Schnall, M. & Chance, B. Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. Proc. Natl Acad. Sci. USA 97, 2767-2772 (2000).
65. Contag, C. H. et al. Photonic detection of bacterial pathogens in living hosts. Mol. Microbiol. 18, 593-603 (1995).
66. Contag, C. H., Jenkins, D., Contag, P. R. & Negrin R. S. Use of reporter genes for optical measurements of neoplastic disease in vivo, Neoplasia 2, 41-52 (2000).
67. Hoegeman, D., Ntziachristos, V., Josephson, L. & Weissleder, R. High throughput MR imaging for evaluating targeted magnetic nanoparticle probes. Bioconj. Chem. (in the press).
68. Louie, A, Y. et al. In vivo visualization of gene expression using magnetic resonance imaging. Nature Biotechnol. 18, 321-325 (2000).
69. Moats, R. A., Fraser, S. E. & Meade, T. J. A 'smart' magnetic resonance imaging agent that reports on specific enzymatic activity. Angew. Chem. Int. Ed. Engl. 36, 726-731 (1997).